Chiba H, Akita H, Kotani K, Kanno T, Manabe M
Department of Laboratory Medicine, Medical Hospital, Hokkaido University School of Medicine, Sapporo.
Rinsho Byori. 1997 Jan;45(1):55-7.
Malondialdehyde-modified LDL(MDA-LDL) is one of the major oxidative LDL. MDA-LDL was determined by enzyme immunoassay in patients with complete and partial cholesteryl ester transfer protein(CETP) deficiency. Significantly increased serum MDA-LDL levels and MDA-LDL/apoB ratios in the LDL fraction were observed in patients with complete CETP deficiency but not for those with partial CETP deficiency. The present results may indicate that patients with complete CETP deficiency have a higher risk for atherosclerosis than those with partial CETP deficiency and normal.
丙二醛修饰的低密度脂蛋白(MDA-LDL)是主要的氧化型低密度脂蛋白之一。采用酶免疫分析法测定了完全性和部分性胆固醇酯转运蛋白(CETP)缺乏症患者的MDA-LDL水平。结果发现,完全性CETP缺乏症患者的血清MDA-LDL水平和低密度脂蛋白组分中的MDA-LDL/载脂蛋白B比值显著升高,而部分性CETP缺乏症患者则无此现象。目前的结果可能表明,完全性CETP缺乏症患者发生动脉粥样硬化的风险高于部分性CETP缺乏症患者和正常人。